Clinical Trials Browser

Phase 3 × Estrogen Antagonists × Clear all

NCT00043069 2016-12-07

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Phase 3 Completed

Osteoporosis, Prostatic Neoplasms